US Capital Partners Provides Multi-Million Dollar Financing for Chantilly BioPha rma, LLC US Capital Partners, LLC has

structured and put in place custom debt financing f or a growing, early-stage Virginia-based specialty pharmaceutical company. San Francisco, CA, August 14, 2013 -- US Capital Partners, LLC has provided expa nsive term loan financing for Chantilly BioPharma, LLC ("CBL"), headquartered in Chantilly, Virginia. US Capital Partners is a private investment bank that make s direct debt investments, participates in debt facilities, and arranges equity placements for small to lower middle market companies. "Our company is engaged in the development, manufacturing, commercialization, li censing, and marketing of proprietary technologies and products for a wide range of pharmaceuticals," said S. Rao Cherukuri, founder and Chairman of CBL. "We ha ve been expanding the business in both the retail and non-retail segments, and n eeded financing for capital expenditure and to support our growing working capit al needs. We approached US Capital Partners for help and are extremely pleased w ith the result." "We are delighted to have provided financing for this Virginia-based specialty p harmaceutical company," said Jeffrey Sweeney, CEO and Managing Director at US Ca pital Partners. "CBL needed our expertise to structure, underwrite, and provide optimal financing to support its continued business growth. US Capital Partners provided expansive term loan financing for CBL, and expedited the timeline to cl ose upon completion of its appraisal report on the business. About Chantilly BioPharma, LLC: Chantilly BioPharma, LLC ("CBL") develops, manufactures, and markets generic pha rmaceuticals and controlled substances using oral drug delivery techniques, includ ing taste masking and controlled release platforms. CBL holds over 50 issued and 11 pending US patents and over 100 international patents and applications that cover its unique drug delivery methods. The company has a state-of-the-art facil ity with up-to-date quality assurance systems for manufacturing, analytical test ing, and packaging of prescription products. About US Capital Partners, LLC: Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing p rompt, innovative, and reliable financing solutions including lending, equity fi nancing, and debt re-structuring to businesses across the United States and abro ad. US Capital Partners is a private investment bank, direct lender, co-lender, and lead financial arranger that specializes in asset-based debt for small to mi ddle market private and public companies. The company s innovative approach allows i t to provide the best financing available, not only for companies in excellent f inancial condition, but also for companies that may have been refused credit by traditional lenders. To learn more about how your business can secure the funding it needs, email Jef frey Sweeney, CEO and Managing Director, at jsweeney@uscapitalpartners.net or ca ll (415) 889-1010. Contact: Hilary Adams US Capital Partners, LLC 555 Montgomery Street, Suite 1501 San Francisco, CA 94111 415-889-1010 james@englishwordfactory.com http://www.uscapitalpartners.net